EP Winer

KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC)

Javier Cortés, Oleg Lipatov, S. Im et al. · Annals of Oncology · 2019 · 132 citations

Medicine, Oncology, Pharmacology +16

Performance of PD-L1 immunohistochemistry (IHC) assays in unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): Post-hoc analysis of IMpassion130

H. S. Rugo, Sherene Loi, Sylvia Adams et al. · Annals of Oncology · 2019 · 115 citations · Full text

Medicine, Oncology, Breast Oncology +13

Trastuzumab/chemotherapy combinations in metastatic breast cancer

JA Ligibel, EP Winer · Seminars in Oncology · 2002 · 86 citations

Medicine, Oncology, Pharmacology +14

Abstract GS1-04: IMpassion130: Efficacy in immune biomarker subgroups from the global, randomized, double-blind, placebo-controlled, phase III study of atezolizumab + <i>nab</i>-paclitaxel in patients with treatment-naïve, locally advanced or metastatic triple-negative breast cancer

LA Emens, Sherene Loi, HS Rugo et al. · Cancer Research · 2019 · 82 citations

Medicine, Oncology, Pharmacology +17

Liposomal anthracyclines for breast cancer

J. A. Sparano, EP Winer · Seminars in Oncology · 2001 · 50 citations

Pharmacy, Oncology, Pharmacology +14